Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. CARMAT
  6. Summary
    ALCAR   FR0010907956

CARMAT

(ALCAR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
29.65(c) 28.7(c) 29.35(c) 30.1(c) 31.5 Last
38 166 32 931 34 858 70 254 69 148 Volume
-2.63% -3.20% +2.26% +2.56% +4.65% Change
More quotes
Estimated financial data (e)
Sales 2021 11,1 M 13,0 M 13,0 M
Net income 2021 -47,5 M -56,0 M -56,0 M
Net cash position 2021 6,10 M 7,19 M 7,19 M
P/E ratio 2021 -9,48x
Yield 2021 -
Sales 2022 14,5 M 17,1 M 17,1 M
Net income 2022 -38,9 M -45,9 M -45,9 M
Net Debt 2022 47,9 M 56,4 M 56,4 M
P/E ratio 2022 -13,0x
Yield 2022 -
Capitalization 461 M 543 M 543 M
EV / Sales 2021 41,1x
EV / Sales 2022 35,1x
Nbr of Employees 119
Free-Float 54,1%
More Financials
Company
Carmat SAS is a France-based Company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical... 
More about the company
Ratings of CARMAT
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about CARMAT
02:58aCARMAT : Wins French Committee's Nod To Use Commercial Version Of Heart Device I..
MT
09/15CARMAT : 2021 interim financial report
PU
09/15GLOBAL MARKETS LIVE : Microsoft, Apple, The Boeing Company, AT&T, Activision Bli..
09/08CARMAT : French gender equality index
PU
09/06Certain Shares of Carmat SA are subject to a Lock-Up Agreement Ending on 6-SE..
CI
09/03GLOBAL MARKETS LIVE : Amazon, Delivery Hero, Walmart, Broadcom, JD.com, Didi Glo..
09/03CARMAT Announces Appointment of Ivo Simundic as Sales Director for the DACH R..
CI
09/03CARMAT : appoints Ivo Simundic as Sales director for the DACH region to support ..
PU
08/27GLOBAL MARKETS LIVE : Nvidia, Microsoft, Dell, Apple, Uber...
08/27CARMAT : Completes Third Commercial Bioprosthetic Heart Implant
MT
08/27CARMAT Announces a New Commercial Implant of Its Aeson® Artificial Heart at U..
CI
08/25GLOBAL MARKETS LIVE : Kering, Delta Air Lines, Pfizer, Moderna, Sony...
07/27Global markets live: LVMH, Michelin, Tesla, Amazon, Activision...
07/27CARMAT : First human implant of the Aeson® artificial heart in Germany
PU
07/26Carmat Announces the First Human Implant of Its Aeson® Artificial Heart in Ge..
CI
More news
News in other languages on CARMAT
03:08aSTOCK MARKET PARIS : Même pas peur des quatre sorcières
03:02aLes valeurs à suivre aujourd'hui à la Bourse de Paris Vendredi 17 septembre 2..
02:58aCarmat obtient le feu vert du comité français pour utiliser la version commer..
02:39aCARMAT : feu vert à l'étude pour la commercialisation d'Aeson en France
02:34aEN DIRECT DES MARCHES : Renault, Unibail, Euronext, Amundi, Invesco, Ryanair, Gr..
More news
Stock Trading Strategies
CARMAT - 2020
The calm spell can be taken advantage of to put on new positions
BUY
More Stock Trading Analysis
Chart CARMAT
Duration : Period :
CARMAT Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARMAT
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 30,10 €
Average target price 41,50 €
Spread / Average Target 37,9%
EPS Revisions
Managers and Directors
Stéphane Piat Chief Executive Officer & Director
Alain Carpentier Honorary President
Pascale d’Arbonneau Chief Financial & Administrative Officer
Jean-Pierre Garnier Chairman
Marc Grimmé Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CARMAT6.36%543
STRYKER CORPORATION12.68%104 120
SMITH & NEPHEW PLC-10.53%16 341
INSPIRE MEDICAL SYSTEMS, INC.29.85%6 661
AXONICS, INC.42.87%3 287
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.-6.25%2 625